Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,991
Total Claims
$948K
Drug Cost
889
Beneficiaries
$1,066
Cost/Patient
Risk Score Breakdown 15/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-9%
Opioid rate vs peers
2.3% vs 2.6% avg
0%
Cost per patient vs peers
$1,066 vs $1,068 avg
+18%
Brand preference vs peers
10.6% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.3%
Opioid Rate
280
Opioid Claims
$4,388
Opioid Cost
3.9%
Long-Acting Rate
Brand vs Generic
Brand: 1,266 claims · $715K
Generic: 10,639 claims · $230K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 91 | $110K |
| Semaglutide | 50 | $85K |
| Tirzepatide | 36 | $54K |
| Dulaglutide | 34 | $45K |
| Rsvpref3 Antigen/As01e/Pf | 126 | $40K |
| Dapagliflozin Propanediol | 39 | $39K |
| Sitagliptin Phosphate | 31 | $34K |
| Linagliptin | 26 | $29K |
| Empagliflozin | 29 | $28K |
| Budesonide/Formoterol Fumarate | 42 | $27K |
| Rivaroxaban | 34 | $24K |
| Linaclotide | 20 | $20K |
| Fluticasone/Vilanterol | 33 | $19K |
| Mirabegron | 24 | $18K |
| Atorvastatin Calcium | 873 | $11K |
Prescribing Profile
Patient Profile
74
Avg Age
73%
Female
1.06
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About